Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Jinjin Zhang, Xiang Dong, Yiyuan Cao, Yibin Yang, Youqin Yan, Cezmi A. Akdiş, Yadong Gao
Allergy · 2020 · 4,090 citationsOpen access
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Zhang, J., Dong, X., Cao, Y., Yuan, Y.- dong, Yang, Y., Yan, Y., Akdiş, C. A., & Gao, Y. (2020). Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in wuhan, china. Allergy, 75(7), 1730–1741. https://doi.org/10.1111/all.14238
In text: (Zhang et al., 2020)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
BACKGROUND: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been widely spread. We aim to investigate the clinical characteristic and allergy status of patients infected with SARS-CoV-2. METHODS: Electronic medical records including demographics, clinical manifestation, comorbidities, laboratory data, and radiological materials of 140 hospitalized COVID-19 patients, with confirmed result of SARS-CoV-2 viral infection, were extracted and analyzed. RESULTS: An approximately 1:1 ratio of male (50.7%) and female COVID-19 patients was found, with an overall median age of 57.0 years. All patients were community-acquired cases. Fever (91.7%), cough (75.0%), fatigue (75.0%), and gastrointestinal symptoms (39.6%) were the most common clinical manifestations, whereas hypertension (30.0%) and diabetes mellitus (12.1%) were the most common comorbidities. Drug hypersensitivity (11.4%) and urticaria (1.4%) were self-reported by several patients. Asthma or other allergic diseases were not reported by any of the patients. Chronic obstructive pulmonary disease (COPD, 1.4%) patients and current smokers (1.4%) were rare. Bilateral ground-glass or patchy opacity (89.6%) was the most common sign of radiological finding. Lymphopenia (75.4%) and eosinopenia (52.9%) were observed in most patients. Blood eosinophil counts correlate positively with lymphocyte counts in severe (r = .486, P < .001) and nonsevere (r = .469, P < .001) patients after hospital admission. Significantly higher levels of D-dimer, C-reactive protein, and procalcitonin were associated with severe patients compared to nonsevere patients (all P < .001). CONCLUSION: Detailed clinical investigation of 140 hospitalized COVID-19 cases suggests eosinopenia together with lymphopenia may be a potential indicator for diagnosis. Allergic diseases, asthma, and COPD are not risk factors for SARS-CoV-2 infection. Older age, high number of comorbidities, and more prominent laboratory abnormalities were associated with severe patients.
Related papers
- Clinical Characteristics of Coronavirus Disease 2019 in China2020
- A Novel Coronavirus from Patients with Pneumonia in China, 20192020
- A pneumonia outbreak associated with a new coronavirus of probable bat origin2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China2020
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine2020
Metadata from OpenAlex (CC0). Citations are generated from the published record.